Plant-Derived Cannabis Formula Granted 'Breakthrough' Designation by FDA for Pain Treatment
June 19, 2026
June 19, 2026
WASHINGTON, June 19 [Category: Sociological] -- The National Organization for the Reform of Marijuana Laws posted the following news release:
* * *
Plant-Derived Cannabis Formula Granted 'Breakthrough' Designation by FDA for Pain Treatment
*
Grafelfing, Germany: Regulators at the US Food and Drug Administration have granted 'Breakthrough Therapy Designation' to a proprietary cannabis extract (VER-01) containing 2.5 milligram . . .
* * *
Plant-Derived Cannabis Formula Granted 'Breakthrough' Designation by FDA for Pain Treatment
*
Grafelfing, Germany: Regulators at the US Food and Drug Administration have granted 'Breakthrough Therapy Designation' to a proprietary cannabis extract (VER-01) containing 2.5 milligram . . .
